Target flexibility: an emerging consideration in drug discovery and design.
Target flexibility: an emerging consideration in drug discovery and design.
复制标题
DOI:
10.1021/jm800562d
复制
发表时间:
2008-10-23
影响因子:
7.3
通讯作者:
Sotriffer CA
中科院分区:
文献类型:
--
作者:
Cozzini P;Kellogg GE;Spyrakis F;Abraham DJ;Costantino G;Emerson A;Fanelli F;Gohlke H;Kuhn LA;Morris GM;Orozco M;Pertinhez TA;Rizzi M;Sotriffer CA
Structure-based drug discovery has played an important role in medicinal chemistry, 1 beginning nearly when the first X-ray crystal structure of the myoglobin and hemoglobin proteins at near-atomic resolution were described by Perutz, Kendrew and colleagues. 2-5 Even though only static structures were (and still generally are) used for most structure-based drug design (SBDDa) and indeed most molecular modeling, the importance of flexibility was recognized immediately: hemoglobin has two rather different structures,“tense” and “relaxed”, depending on its oxygenation, although in recent years a family of relaxed hemoglobin structures with different tertiary structure conformations have been reported. 6 In fact, all proteins are inherently flexible systems. This flexibility is frequently essential for function (eg, as in hemoglobin). Proteins have an intrinsic ability to undergo functionally relevant conformational transitions under native state conditions7, 8 on a wide range of scales, both in time and space. 9 In adenylate kinase large conformational changes due to movements of the nucleotide “lids”(ratelimiting for overall catalytic turnover10, 11) are “linked” with
登录
查看更多内容
影响因子:
3.5
作者:
Bottegoni, Giovanni;Kufareva, Irina;Abagyan, Ruben
通讯作者:
Abagyan, Ruben
影响因子:
3
作者:
BROOKS, BR;BRUCCOLERI, RE;KARPLUS, M
通讯作者:
KARPLUS, M
影响因子:
7.3
作者:
Cioffi, Marina;Hunter, Christopher A.;Spitaleri, Andrea
通讯作者:
Spitaleri, Andrea
影响因子:
3.4
作者:
Chen, W;Chang, CE;Gilson, MK
通讯作者:
Gilson, MK
影响因子:
3.4
作者:
Atilgan, AR;Durell, SR;Bahar, I
通讯作者:
Bahar, I